In my 10+ years of co-survivorship, doing life with @DGlaucomflecken through 2 separate cancers, 1 SCA and fighting off his death with 10 mins of #CPR, only ONE (1) of the medical professionals we interacted with has ever asked how I was doing. Meet Roger. https://t.co/NR4F2mkcZC
Humbled and proud to chair the International Advisory Committee on Clinical Trials in #MultipleSclerosis which is jointly supported by @ECTRIMS and US @mssociety I look forward to the new revision of the #McDonald diagnostic criteria in late 2023. https://t.co/GPmcArZjq8…
Kesimpta vs. Aubagio. Those started on kesimpta 3 years earlier are projected to be more likely (57.0% vs 44.0% compared to Aubagio) to have mild disability (EDSS 0–3) after 10 years according to this analysis of the ASCLEPIOS trial from Spain. https://t.co/jOmNEbsTGf
Hey @DGlaucomflecken, did you know that @UHC online & phone systems were down last week but magically came alive on Thanksgiving, at which point they left several voicemails re: surgery denials for our practice schedulers. On Thanksgiving. That timing is quite convenient huh.